August 3, 2018 Source: MobiHealthNews 730
New sponsor OCA Ventures along with existing financiers have granted $1 million in Series A funding to PatientWisdom, a digital health corporation working on real-world data compilation tools. The company’s total funding is now worth $3.45 million.
The company’s software collection encompasses PatientWisdom, which assembles data to enhance patient experience and care services, ProviderWisdom, which applies information to engender healthcare provider-level views to develop engagement and care while preventing exhaustion, and CommunityWisdom, which gives organizations a vivid picture of the wide patient population.
“The missing link in healthcare is understanding what matters to the people involved,” Gregory Makoul, founder and CEO of PatientWisdom, said in a statement. “We are leveraging communication science to improve health and care by focusing on what matters, bringing new meaning to ‘personalized’ medicine.”
Referring to a statement, PatientWisdom aims to employ the new funding to present the set of tools to the market by empowering its sales competence. The company will also improve implementation of the pooled data by developing its platforms and creating new analytic skills.
Till now, PatientWisdom’s products have been distributed to Yale New Haven Health, Froedtert & the Medical College of Wisconsin, and OSF Health, all being strategic allies having invested in the company. PatientWisdom’s website reveals that the company is also teaming up with the Healthcare Transformation Lab at Massachusetts General Hospital and the Signal Center for Health Innovation at the University of Iowa Health Care.
“We have been following PatientWisdom, Inc. closely and see their scalable approach to focusing on what matters as highly overdue, unique, and valuable. We are delighted to help fuel the company’s growth,” Bob Saunders, general partner at OCA Ventures, said in a statement.
By Dduyour submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.